The same is the case for Galectin-3 (LGALS3) and Galectin-4 (LGALS4), associated with gastro-intestinal cancers, which are downregulated in colorectal (COREAD) but upregulated in pancreatic cancer (PAAD). This evidence concerns the gene LGALS3 and pancreatic neoplasm.